AI-enabled medical technologies require robust clinical evidence to support their safe and effective use in clinical practice. In this case study, Cyrill Gyger and Jonas Reber introduce their QUMEA’s AI-enabled, radar-based system for contactless patient monitoring. They highlight QUMEA’s distinct approach to product development, in which regulatory requirements were integrated into the design process from the outset, shaping the system’s architecture, capabilities, and market positioning.